PWA
GILD icon

Physician Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Physician Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.1K Sell
460
-32
-7% -$4.22K 0.01% 403
2026
Q1 		$68.6K Buy
492
+53
+12% +$7.42K 0.01% 337
2025
Q4 		$53.9K Buy
439
+46
+12% +$5.59K 0.01% 376
2025
Q3 		$43.6K Buy
393
+328
+505% +$37.3K 0.01% 398
2025
Q2 		$7.21K Sell
65
-2
-3% -$213 ﹤0.01% 714
2025
Q1 		$7.51K Buy
67
+51
+319% +$5.26K ﹤0.01% 660
2024
Q4 		$1.48K Buy
+16
New +$1.44K ﹤0.01% 879

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Physician Wealth Advisors's GILD Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Gilead Sciences (GILD) stake by 6.5% in Q2 2026, selling an estimated $4.22K and leaving 460 shares worth $58.1K. The position accounts for 0.01% of the portfolio, ranked #403.

Physician Wealth Advisors first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $68.6K in Q1 2026. 535 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Physician Wealth Advisors held 460 shares of Gilead Sciences worth $58.1K as of Q2 2026.
  • Physician Wealth Advisors sold 32 Gilead Sciences shares in Q2 2026, an estimated $4.22K.
  • Gilead Sciences made up 0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #403 holding.
  • Physician Wealth Advisors first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Physician Wealth Advisors's Gilead Sciences position peaked at $68.6K in Q1 2026.
  • 535 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.